Craig L Hanis

Title: Craig L Hanis: Innovator in Diabetes Research

Introduction

Craig L Hanis is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of diabetes research, particularly through his innovative work on polynucleotides.

Latest Patents

Hanis holds a patent for "Polynucleotides encoding calpain 10." This invention relates to the identification of genes responsible for non-insulin-dependent diabetes mellitus (NIDDM1). It demonstrates that the NIDDM1 locus corresponds to the calpain 10 gene. The invention also highlights that analyzing mutations in calpain genes can serve as a diagnostic tool for type 2 diabetes. Furthermore, it contemplates methods for treating diabetes based on the understanding that calpain mutations can lead to the disease. The invention includes novel polynucleotides of the NIDDM1 locus and the polypeptides encoded by these polynucleotides. Hanis has 1 patent to his name.

Career Highlights

Throughout his career, Hanis has focused on the genetic aspects of diabetes, contributing valuable insights into the mechanisms underlying the disease. His work has implications for both diagnostics and therapeutic strategies in managing diabetes.

Collaborations

Hanis has collaborated with notable researchers in the field, including Yukio Horikawa and Naohisa Oda. These collaborations have further enriched his research and expanded the impact of his findings.

Conclusion

Craig L Hanis is a significant figure in diabetes research, with a focus on genetic factors that contribute to the disease. His innovative work continues to influence the field and offers hope for improved diagnostic and therapeutic approaches.